Cost-Utility Analysis of Lurasidone Versus Aripiprazole in Adults with Schizophrenia
Crossref DOI link: https://doi.org/10.1007/s40273-016-0405-0
Published Online: 2016-04-11
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Rajagopalan, Krithika
Trueman, David
Crowe, Lydia
Squirrell, Daniel
Loebel, Antony
License valid from 2016-04-11